用于改善和加速多发性骨髓瘤患者脊柱纵向受累CT监测的自动化「骨减影」图像分析软件包
回顾性纳入82例多发性骨髓瘤患者共188次重复全身低剂量MDCT,评估新型CT后处理软件生成纵向非增强CT减影图监测脊柱骨髓瘤骨病病程的诊断价值。骨减影图联合1 mm源图像阅片较标准5 mm轴位+2 mm MPR阅片在逐病灶判读中敏感度、特异度、准确率略有提高,并使9.7%患者(n=8)的疗效分类由稳定转为进展,阅片时间显著缩短。
要点
- 骨减影图逐病灶判读敏感度97.8%、特异度96.7%、准确率97.7%,略高于标准5 mm轴位+2 mm MPR阅片的97.6%、92.3%、97.2%。
- 使用骨减影图使9.7%患者(n=8)的疗效分类由稳定转为进展,而标准5 mm+2 mm MPR阅片未出现该改变。
- 骨减影图阅片时间较标准阅片(P<0.01)及1 mm图像阅片(P<0.001)显著缩短。
核心结论
- 骨减影图监测多发性骨髓瘤的准确率较常规轴位+MPR图像阅片略有提高,并显著加快阅片时间。
研究设计与样本
- 回顾性数据评估,经当地机构审查委员会批准,纳入2013年12月至2016年1月在本院接受188次重复全身低剂量多层探测器CT(MDCT)的82例连续骨髓瘤患者(46例男性;平均年龄65.08±9.76岁)。
关键影像表现/征象
- 溶骨性骨病灶分为新发或增大 versus 稳定。
- 骨减影图与对应1 mm源图像联合阅片,并与标准5 mm轴位及2 mm多平面重建(MPR)图像阅片及血液学标志物比较,分类为进展性疾病(PD)或稳定疾病(SD或缓解)。
- 82例患者中52例(63.4%)检出骨硬化病灶。
诊断标准与关键数值
- 参考标准为1 mm轴位CT图像阅片+血液学缓解,二者均在随访中确认。
- 按参考标准,随访中16例患者为PD、66例为SD。
- 逐病灶判读:5 mm轴位+2 mm MPR图像敏感度97.6%、特异度92.3%、准确率97.2%;骨减影图敏感度97.8%、特异度96.7%、准确率97.7%。
临床应用与阅片要点
- 骨减影图联合1 mm源图像阅片用于监测脊柱骨髓瘤骨病,逐病灶判读的敏感度、特异度、准确率略高于标准5 mm轴位+2 mm MPR阅片。
- 使用骨减影图可使部分按标准阅片判为稳定的患者改判为进展(9.7%,n=8)。
- 骨减影图阅片时间较标准阅片(P<0.01)和1 mm图像阅片(P<0.001)显著缩短。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: The study aimed to assess the diagnostic benefit of a novel computed tomography (CT) post-processing software generating subtraction maps of longitudinal non-enhanced CT examinations for monitoring the course of myeloma bone disease in the spine.
MATERIALS AND METHODS: The local institutional review board approved the retrospective data evaluation. Included were 82 consecutive myeloma patients (46 male; mean age, 65.08 ± 9.76) who underwent 188 repeated whole-body reduced-dose Multislice Detector Computed Tomography (MDCT) at our institution between December 2013 and January 2016. Lytic bone lesions were categorized as new or enlarging versus stable. Bone subtraction maps were read in combination with corresponding 1-mm source images comparing results to those of standard image reading of 5-mm axial and 2-mm multiplanar reformat reconstructions (MPR) scans and hematologic markers, and classified as either progressive disease (PD) or stable disease (SD or remission). The standard of reference was 1-mm axial CT image reading + hematologic response both confirmed at follow-up. For statistical purposes, we subgrouped the hematologic response categories similarly to those applied for CT imaging (progression vs stable/response).
RESULTS: According to the standard of reference, 16 patients experienced PD and 66 SD at follow-up. Th sensitivity, specificity, and accuracy for axial 5 mm + 2 mm MPR image versus bone subtraction maps in a "lesion-by-lesion" reading were 97.6%, 92.3%, and 97.2% versus 97.8%, 96.7%, and 97.7%, respectively. The use of bone subtraction maps resulted in a change of response classification in 9.7% of the patients (n = 8) versus 5 mm + 2 mm MPR image reading from SD to PD. Bone sclerosis lesions were detected in 52 out of 82 patients (63.4%). The reading time was significantly lower with the software bone subtraction compared to standard reading (P < 0.01) and 1-mm image reading (P < 0.001).
CONCLUSION: Accuracy of bone subtraction maps reading for monitoring multiple myeloma is slightly increased over that of conventional axial + MPR image reading and significantly speeds up the reading time.
引用
- Horger M, Ditt H, Liao S, et al. Automated "Bone Subtraction" Image Analysis Software Package for Improved and Faster CT Monitoring of Longitudinal Spine Involvement in Patients with Multiple Myeloma. Acad Radiol. 2017. PMID: 28256439. doi:10.1016/j.acra.2016.12.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。